Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Piedmont Reference Center for Epidemiology and Cancer Prevention, Emory University, Cancer Institute (WIA), National and Kapodistrian University of Athens, Azienda Ospedaliero Universitaria San Giovanni Battista, Dalhousie University, Medical University of Silesia, Charles University, Medical University of Lublin, Complejo Hospitalario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Rabin Medical Center, Tel Aviv University, University of Alberta, Princess Margaret Cancer Centre, Ankara University, Alfred Health, Monash University, Barts Health NHS Trust, The University of Texas MD Anderson Cancer Center, Kyoto Prefectural University of Medicine, TU Dresden, Klinik und Poliklinik für Psychotherapie und Psychosomatik, Universitätsklinikum Würzburg, Ziekenhuisnetwerk Antwerpen Stuivenberg, AbbVie (United States), Navarre Institute of Health Research, Clinica Universidad de Navarra, Bristol-Myers Squibb (United States), Wallingford Public Library, Dana-Farber Cancer Institute